oil, currencies, exchange rate, interest rate, financial index, securities index as goods or variable, or any other assets or variables as specified in the Notification of the Office; “financial

installed in Q2/2018 – Q1/2019. However, the main variable costs including raw materials and consumables used decreased from the previous year as the production slowed down. The only selling and

selling expenses is variable expenses associated with condominium unit sale: commission, specific business tax and commercial fee (sale). 3.2. The company‘s administrative expenses in quarter 2nd of year

to revenue from sale ratio is 73.24 %, 70.82 % and 77.04 %, for year 2020, 2021, and 2022 respectively. The main reason is that in 2022, the company has increased variable costs such as raw material

. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public

/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the

optimizing costs has shown good progress. This will continue as the impact from the integration of Saraburi Quicklime has an effect. On the variable cost side fuel costs were higher than in the same period

employee incentive programs. On the variable cost side fuel costs were higher than in the same period last year and also in fixed costs related to production maintenance cost increased due to the earlier